(FY)Dec 31, 2023 | (Q9)Sep 30, 2023 | (Q6)Jun 30, 2023 | (Q3)Mar 31, 2023 | (FY)Dec 31, 2022 | (Q9)Sep 30, 2022 | (Q6)Jun 30, 2022 | (Q3)Mar 31, 2022 | (FY)Dec 31, 2021 | (Q9)Sep 30, 2021 | |
---|---|---|---|---|---|---|---|---|---|---|
Turnover | 145.63%113.74B | 138.60%85.54B | 155.37%49.43B | 75.77%22.26B | -31.02%46.31B | -31.72%35.85B | -44.24%19.35B | -5.45%12.67B | 14.30%67.13B | 24.12%52.5B |
Operating income | 145.63%113.74B | 138.60%85.54B | 155.37%49.43B | 75.77%22.26B | -31.02%46.31B | -31.72%35.85B | -44.24%19.35B | -5.45%12.67B | 14.30%67.13B | 24.12%52.5B |
Operating expenses | -43.73%-80.96B | -25.99%-24.18B | 5.23%-56.33B | -7.63%-19.2B | -16.75%-59.44B | |||||
Gross profit | 122.34%4.58B | 70.57%-1.92B | -195.14%-20.48B | -47.07%-6.53B | 19.43%-6.94B | |||||
Selling expenses | -249.46%-2.93B | -86.61%-3.11B | -335.06%-1.34B | -56.50%-867M | 25.62%-839M | 28.11%-1.67B | 60.16%-308M | 18.05%-554M | 28.15%-1.13B | 11.67%-2.32B |
Administrative expenses | ---- | 5.47%-2.44B | ---- | 2.36%-785M | ---- | -2.06%-2.58B | ---- | -13.88%-804M | ---- | -11.04%-2.53B |
Research and development expenses | ---- | -5.83%-218M | ---- | -16.00%-87M | ---- | -7.29%-206M | ---- | -70.45%-75M | ---- | 0.52%-192M |
Profit from asset sales | ---- | -25.00%9M | ---- | -58.33%5M | ---- | --12M | ---- | 1,300.00%12M | ---- | ---- |
Employee expense | -15.27%-23.61B | ---- | -13.24%-10.92B | ---- | 2.73%-20.49B | ---- | 9.90%-9.65B | ---- | -1.12%-21.06B | ---- |
Depreciation and amortization | -14.73%-25.02B | ---- | -14.54%-12.21B | ---- | 3.99%-21.81B | ---- | 4.98%-10.66B | ---- | -2.08%-22.72B | ---- |
Revaluation surplus | 41.67%-7M | 86.67%-2M | 83.33%-1M | 80.00%-1M | -9.09%-12M | -114.29%-15M | -300.00%-6M | -141.67%-5M | 57.69%-11M | 75.86%-7M |
-Changes in the fair value of financial assets | 41.67%-7M | ---- | 83.33%-1M | ---- | -9.09%-12M | ---- | -300.00%-6M | ---- | 57.69%-11M | ---- |
-Changes in the fair value of other assets | ---- | 86.67%-2M | ---- | 80.00%-1M | ---- | -114.29%-15M | ---- | -141.67%-5M | ---- | 75.86%-7M |
Impairment and provision | 42.40%-72M | -633.33%-44M | -450.00%-44M | --0 | -150.00%-125M | -20.00%-6M | -166.67%-8M | --0 | 76.85%-50M | 83.87%-5M |
-Other impairment is provision | 42.40%-72M | -633.33%-44M | -450.00%-44M | --0 | -150.00%-125M | -20.00%-6M | -166.67%-8M | --0 | 76.85%-50M | 83.87%-5M |
Special items of operating profit | -84.90%-64.01B | 63.85%3.83B | -90.42%-27.51B | 11.28%937M | 2.96%-34.62B | -38.34%2.34B | 17.40%-14.45B | -39.21%842M | -28.92%-35.68B | 2.66%3.79B |
Operating profit | 93.92%-1.92B | 110.47%2.38B | 83.48%-2.6B | 61.08%-2.78B | -133.67%-31.59B | -171.63%-22.73B | -187.16%-15.72B | -58.44%-7.14B | 2.33%-13.52B | 17.38%-8.37B |
Financing income | -3.32%495M | ---- | 30.95%275M | ---- | -73.85%512M | ---- | -77.89%210M | ---- | -26.39%1.96B | ---- |
Financing cost | 20.96%-6.98B | 23.15%-5.62B | -4.25%-4.66B | -4.97%-1.22B | -51.98%-8.83B | -125.94%-7.31B | -61.17%-4.47B | -4.29%-1.17B | -11.49%-5.81B | -9.96%-3.24B |
Share of profits of associates | 174.19%115M | ---- | 157.14%18M | ---- | -59.79%-155M | ---- | -69.57%7M | ---- | -18.29%-97M | ---- |
Share of profit from joint venture company | 126.00%13M | ---- | 80.00%-6M | ---- | -13.64%-50M | ---- | -233.33%-30M | ---- | -238.46%-44M | ---- |
Special items of earning before tax | ---- | 72.28%174M | ---- | -68.52%17M | ---- | -30.82%101M | ---- | 63.64%54M | ---- | -37.61%146M |
Earning before tax | 79.36%-8.28B | 89.77%-3.06B | 65.16%-6.97B | 51.70%-3.99B | -129.05%-40.11B | -161.31%-29.94B | -174.66%-20B | -47.59%-8.25B | -6.22%-17.51B | 10.74%-11.46B |
Tax | -237.70%-336M | 6,928.57%492M | 1,752.38%389M | 18.75%-13M | -94.23%244M | -99.76%7M | -98.88%21M | -101.08%-16M | 7.69%4.23B | -8.81%2.88B |
After-tax profit from continuing operations | 78.39%-8.61B | 91.41%-2.57B | 67.07%-6.58B | 51.64%-4B | -200.14%-39.87B | -248.88%-29.93B | -270.03%-19.97B | -101.05%-8.27B | -5.76%-13.28B | 11.37%-8.58B |
After-tax profit from non-continuing business | ---- | ---- | ---- | --0 | ---- | ---- | ---- | --0 | ---- | ---- |
Earning after tax | 78.39%-8.61B | 91.41%-2.57B | 67.07%-6.58B | 51.64%-4B | -200.14%-39.87B | -248.88%-29.93B | -270.03%-19.97B | -101.05%-8.27B | -5.76%-13.28B | 11.37%-8.58B |
Minority profit | 82.26%-446M | 102.04%37M | 73.51%-328M | 61.49%-196M | -134.95%-2.51B | -334.93%-1.82B | -551.58%-1.24B | -65.26%-509M | -47.59%-1.07B | 27.43%-418M |
Profit attributable to shareholders | 78.13%-8.17B | 90.73%-2.61B | 66.65%-6.25B | 50.99%-3.8B | -205.85%-37.36B | -244.47%-28.12B | -259.75%-18.74B | -103.94%-7.76B | -3.19%-12.21B | 10.36%-8.16B |
Basic earnings per share | 81.31%-0.37 | 92.15%-0.117 | 71.72%-0.28 | 58.54%-0.17 | -171.23%-1.98 | -198.96%-1.4897 | -209.38%-0.99 | -78.26%-0.41 | -1.39%-0.73 | 11.14%-0.4983 |
Diluted earnings per share | 81.31%-0.37 | 92.15%-0.117 | 71.72%-0.28 | 58.54%-0.17 | -171.23%-1.98 | -198.96%-1.4897 | -209.38%-0.99 | -78.26%-0.41 | -1.39%-0.73 | 11.14%-0.4983 |
Currency Unit | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY |
Accounting Standards | IAS | CAS (2007) | IAS | CAS (2007) | IAS | CAS (2007) | IAS | CAS (2007) | IAS | CAS (2007) |
Audit Opinions | Unqualified Opinion | -- | -- | -- | Unqualified Opinion | -- | -- | -- | Unqualified Opinion | -- |
Auditor | PricewaterhouseCoopers, PricewaterhouseCoopers Zhongtian Certified Public Accountants (Special General Partnership) | -- | -- | -- | PricewaterhouseCoopers, PricewaterhouseCoopers Zhongtian Certified Public Accountants (Special General Partnership) | -- | -- | -- | PricewaterhouseCoopers, PricewaterhouseCoopers Zhongtian Certified Public Accountants (Special General Partnership) | -- |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.
No Data
No Data